Do overweight individuals exhibit reduced cardiopulmonary fitness after recovering from COVID-19?

As Con­gress re­turns from Au­gust re­cess, phar­ma and health in­dus­try groups are mak­ing cas­es for why health­care costs should be low­er or more trans­par­ent aimed

At the American Society of Clinical Oncology (ASCO) annual meeting, researchers reported the results of pembrolizumab (Keytruda), a PD-1 immune checkpoint inhibitor, with or without